サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1318665

世界のゲフィチニブAPI市場：考察と予測 (2029年まで)

Global Gefitinib API Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 109 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
世界のゲフィチニブAPI市場：考察と予測 (2029年まで)
出版日: 2023年08月01日
発行: QYResearch
ページ情報: 英文 109 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ゲフィチニブAPI (Gefitinib API) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • ゲフィチニブAPIの製品概要
  • 市場：タイプ別
    • 世界のゲフィチニブAPI 市場規模：タイプ別, 2018 VS 2022 VS 2029
    • Purity ≥ 98 %
    • Purity ≥ 99 %
  • 市場：用途別
    • 世界のゲフィチニブAPI 市場規模：用途別, 2018 VS 2022 VS 2029
    • Gefitinib Tablets
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界のゲフィチニブAPIの生産

  • 世界のゲフィチニブAPIの生産能力 (2018-2029)
  • 世界のゲフィチニブAPIの生産 地域別: 2018 VS 2022 VS 2029
  • 世界のゲフィチニブAPIの生産 地域別
    • 世界のゲフィチニブAPIの生産実績：地域別 (2018-2023)
    • 世界のゲフィチニブAPIの生産予測：地域別 (2024-2029)
    • 世界のゲフィチニブAPIの生産 市場 シェア 地域別 (2018-2029)
  • 北米
  • 欧州
  • 中国
  • 日本

第3章 レポート概要

  • 世界のゲフィチニブAPIの収益 推定および予測 2018-2029
  • 世界のゲフィチニブAPIの収益：地域別
    • 世界のゲフィチニブAPIの収益：地域別: 2018 VS 2022 VS 2029
    • 世界のゲフィチニブAPIの収益：地域別 (2018-2023)
    • 世界のゲフィチニブAPIの収益：地域別 (2024-2029)
    • 世界のゲフィチニブAPIの収益市場シェア 地域別 (2018-2029)
  • 世界のゲフィチニブAPI売上予測・予想 2018-2029
  • 世界のゲフィチニブAPIの販売：地域別
    • 世界のゲフィチニブAPIの販売：地域別: 2018 VS 2022 VS 2029
    • 世界のゲフィチニブAPIの販売：地域別 (2018-2023)
    • 世界のゲフィチニブAPIの販売：地域別 (2024-2029)
    • 世界のゲフィチニブAPIの販売市場シェア 地域別 (2018-2029)
  • US & カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第4章 競合：企業別

  • 世界のゲフィチニブAPIの販売：企業別
    • 世界のゲフィチニブAPIの販売：企業別 (2018-2023)
    • 世界のゲフィチニブAPIの販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： ゲフィチニブAPI in 2022
  • 世界のゲフィチニブAPIの収益：企業別
    • 世界のゲフィチニブAPIの収益：企業別 (2018-2023)
    • 世界のゲフィチニブAPIの収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： ゲフィチニブAPIの収益 2022
  • 世界のゲフィチニブAPIの販売価格：企業別
  • 世界の主要企業 ゲフィチニブAPI, 業界ランキング, 2021 VS 2022 VS 2023
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界のゲフィチニブAPIの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー ゲフィチニブAPI, 製造拠点分布と本社
  • 世界の主要メーカー ゲフィチニブAPI, 提供製品と用途
  • 世界の主要メーカー ゲフィチニブAPI, 業界参入時期
  • M&A, 拡張計画

第5章 市場規模：タイプ別

  • 世界のゲフィチニブAPIの販売：タイプ別
    • 世界のゲフィチニブAPIの販売実績：タイプ別 (2018-2023)
    • 世界のゲフィチニブAPIの販売予測：タイプ別 (2024-2029)
    • 世界のゲフィチニブAPIの販売市場シェア：タイプ別 (2018-2029)
  • 世界のゲフィチニブAPI 収益：タイプ別
    • 世界のゲフィチニブAPIの収益実績：タイプ別 (2018-2023)
    • 世界のゲフィチニブAPIの収益予測：タイプ別 (2024-2029)
    • 世界のゲフィチニブAPIの収益市場シェア：タイプ別 (2018-2029)
  • 世界のゲフィチニブAPIの価格：タイプ別
    • 世界のゲフィチニブAPIの価格：タイプ別 (2018-2023)
    • 世界のゲフィチニブAPIの価格予測：タイプ別 (2024-2029)

第6章 市場規模：用途別

  • 世界のゲフィチニブAPIの販売：用途別
    • 世界のゲフィチニブAPIの販売実績：用途別 (2018-2023)
    • 世界のゲフィチニブAPIの販売予測：用途別 (2024-2029)
    • 世界のゲフィチニブAPIの販売市場シェア：用途別 (2018-2029)
  • 世界のゲフィチニブAPIの収益：用途別
    • 世界のゲフィチニブAPIの収益実績：用途別 (2018-2023)
    • 世界のゲフィチニブAPIの収益予測：用途別 (2024-2029)
    • 世界のゲフィチニブAPIの収益市場シェア：用途別 (2018-2029)
  • 世界のゲフィチニブAPIの価格：用途別
    • 世界のゲフィチニブAPIの価格：用途別 (2018-2023)
    • 世界のゲフィチニブAPIの価格予測：用途別 (2024-2029)

第7章 US & カナダ

  • US & カナダ ゲフィチニブAPI 市場規模：タイプ別
    • US & カナダ ゲフィチニブAPIの販売：タイプ別 (2018-2029)
    • US & カナダ ゲフィチニブAPI 収益：タイプ別 (2018-2029)
  • US & カナダ ゲフィチニブAPI 市場規模：用途別
    • US & カナダ ゲフィチニブAPIの販売：用途別 (2018-2029)
    • US & カナダ ゲフィチニブAPIの収益：用途別 (2018-2029)
  • US & カナダ ゲフィチニブAPIの販売：国別
    • US & カナダ ゲフィチニブAPIの収益：国別: 2018 VS 2022 VS 2029
    • US & カナダ ゲフィチニブAPIの販売：国別 (2018-2029)
    • US & カナダ ゲフィチニブAPIの収益：国別 (2018-2029)
    • 米国
    • カナダ

第8章 欧州

  • 欧州のゲフィチニブAPI 市場規模：タイプ別
    • 欧州のゲフィチニブAPIの販売：タイプ別 (2018-2029)
    • 欧州のゲフィチニブAPI 収益：タイプ別 (2018-2029)
  • 欧州のゲフィチニブAPI 市場規模：用途別
    • 欧州のゲフィチニブAPIの販売：用途別 (2018-2029)
    • 欧州のゲフィチニブAPIの収益：用途別 (2018-2029)
  • 欧州のゲフィチニブAPIの販売：国別
    • 欧州のゲフィチニブAPIの収益：国別: 2018 VS 2022 VS 2029
    • 欧州のゲフィチニブAPIの販売：国別 (2018-2029)
    • 欧州のゲフィチニブAPIの収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 中国

  • 中国のゲフィチニブAPI 市場規模：タイプ別
    • 中国のゲフィチニブAPIの販売：タイプ別 (2018-2029)
    • 中国のゲフィチニブAPI 収益：タイプ別 (2018-2029)
  • 中国のゲフィチニブAPI 市場規模：用途別
    • 中国のゲフィチニブAPIの販売：用途別 (2018-2029)
    • 中国のゲフィチニブAPIの収益：用途別 (2018-2029)

第10章 アジア（中国を除く）

  • アジア地域 ゲフィチニブAPI 市場規模：タイプ別
    • アジア地域 ゲフィチニブAPIの販売：タイプ別 (2018-2029)
    • アジア地域 ゲフィチニブAPI 収益：タイプ別 (2018-2029)
  • アジア地域 ゲフィチニブAPI 市場規模：用途別
    • アジア地域 ゲフィチニブAPIの販売：用途別 (2018-2029)
    • アジア地域 ゲフィチニブAPIの収益：用途別 (2018-2029)
  • アジア地域 ゲフィチニブAPIの販売：地域別
    • アジア地域 ゲフィチニブAPIの収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 ゲフィチニブAPIの収益：地域別 (2018-2029)
    • アジア地域 ゲフィチニブAPIの販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第11章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPI 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPI 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPI 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの販売：国別
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのゲフィチニブAPIの販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第12章 企業プロファイル

  • Scion Pharm Taiwan
  • Farmhispania Group
  • Chem Genix
  • Jeil Pharmaceutical
  • Zhuhai Rundu Pharma
  • Cipla
  • Brawn Laboratories
  • Nischem International
  • Zhejiang Hisun Pharmaceutical
  • Qilu Pharmaceutial

第13章 業界チェーンと販売チャネルの分析

  • ゲフィチニブAPI 業界チェーン分析
  • ゲフィチニブAPI 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • ゲフィチニブAPI 生産形態とプロセス
  • ゲフィチニブAPI 販売およびマーケティング
    • ゲフィチニブAPI 販売チャネル
    • ゲフィチニブAPI 卸業者
  • ゲフィチニブAPI 顧客

第14章 ゲフィチニブAPI 市場動向

  • ゲフィチニブAPI 業界動向
  • ゲフィチニブAPI 市場の促進要因
  • ゲフィチニブAPI 市場の課題
  • ゲフィチニブAPI 市場の抑制要因

第15章 世界のゲフィチニブAPIの主な市場調査結果

第16章 付録

図表

List of Tables

  • Table 1. Global Gefitinib API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Purity ≥ 98 %
  • Table 3. Major Manufacturers of Purity ≥ 99 %
  • Table 4. Global Gefitinib API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Gefitinib API Production by Region: 2018 VS 2022 VS 2029 (MT)
  • Table 6. Global Gefitinib API Production by Region (2018-2023) & (MT)
  • Table 7. Global Gefitinib API Production by Region (2024-2029) & (MT)
  • Table 8. Global Gefitinib API Production Market Share by Region (2018-2023)
  • Table 9. Global Gefitinib API Production Market Share by Region (2024-2029)
  • Table 10. Global Gefitinib API Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Gefitinib API Revenue by Region (2018-2023) & (US$ Million)
  • Table 12. Global Gefitinib API Revenue by Region (2024-2029) & (US$ Million)
  • Table 13. Global Gefitinib API Revenue Market Share by Region (2018-2023)
  • Table 14. Global Gefitinib API Revenue Market Share by Region (2024-2029)
  • Table 15. Global Gefitinib API Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 16. Global Gefitinib API Sales by Region (2018-2023) & (MT)
  • Table 17. Global Gefitinib API Sales by Region (2024-2029) & (MT)
  • Table 18. Global Gefitinib API Sales Market Share by Region (2018-2023)
  • Table 19. Global Gefitinib API Sales Market Share by Region (2024-2029)
  • Table 20. Global Gefitinib API Sales by Manufacturers (2018-2023) & (MT)
  • Table 21. Global Gefitinib API Sales Share by Manufacturers (2018-2023)
  • Table 22. Global Gefitinib API Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 23. Global Gefitinib API Revenue Share by Manufacturers (2018-2023)
  • Table 24. Gefitinib API Price by Manufacturers 2018-2023 (USD/Kg)
  • Table 25. Global Key Players of Gefitinib API, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 26. Global Gefitinib API Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 27. Global Gefitinib API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gefitinib API as of 2022)
  • Table 28. Global Key Manufacturers of Gefitinib API, Manufacturing Base Distribution and Headquarters
  • Table 29. Global Key Manufacturers of Gefitinib API, Product Offered and Application
  • Table 30. Global Key Manufacturers of Gefitinib API, Date of Enter into This Industry
  • Table 31. Mergers & Acquisitions, Expansion Plans
  • Table 32. Global Gefitinib API Sales by Type (2018-2023) & (MT)
  • Table 33. Global Gefitinib API Sales by Type (2024-2029) & (MT)
  • Table 34. Global Gefitinib API Sales Share by Type (2018-2023)
  • Table 35. Global Gefitinib API Sales Share by Type (2024-2029)
  • Table 36. Global Gefitinib API Revenue by Type (2018-2023) & (US$ Million)
  • Table 37. Global Gefitinib API Revenue by Type (2024-2029) & (US$ Million)
  • Table 38. Global Gefitinib API Revenue Share by Type (2018-2023)
  • Table 39. Global Gefitinib API Revenue Share by Type (2024-2029)
  • Table 40. Gefitinib API Price by Type (2018-2023) & (USD/Kg)
  • Table 41. Global Gefitinib API Price Forecast by Type (2024-2029) & (USD/Kg)
  • Table 42. Global Gefitinib API Sales by Application (2018-2023) & (MT)
  • Table 43. Global Gefitinib API Sales by Application (2024-2029) & (MT)
  • Table 44. Global Gefitinib API Sales Share by Application (2018-2023)
  • Table 45. Global Gefitinib API Sales Share by Application (2024-2029)
  • Table 46. Global Gefitinib API Revenue by Application (2018-2023) & (US$ Million)
  • Table 47. Global Gefitinib API Revenue by Application (2024-2029) & (US$ Million)
  • Table 48. Global Gefitinib API Revenue Share by Application (2018-2023)
  • Table 49. Global Gefitinib API Revenue Share by Application (2024-2029)
  • Table 50. Gefitinib API Price by Application (2018-2023) & (USD/Kg)
  • Table 51. Global Gefitinib API Price Forecast by Application (2024-2029) & (USD/Kg)
  • Table 52. US & Canada Gefitinib API Sales by Type (2018-2023) & (MT)
  • Table 53. US & Canada Gefitinib API Sales by Type (2024-2029) & (MT)
  • Table 54. US & Canada Gefitinib API Revenue by Type (2018-2023) & (US$ Million)
  • Table 55. US & Canada Gefitinib API Revenue by Type (2024-2029) & (US$ Million)
  • Table 56. US & Canada Gefitinib API Sales by Application (2018-2023) & (MT)
  • Table 57. US & Canada Gefitinib API Sales by Application (2024-2029) & (MT)
  • Table 58. US & Canada Gefitinib API Revenue by Application (2018-2023) & (US$ Million)
  • Table 59. US & Canada Gefitinib API Revenue by Application (2024-2029) & (US$ Million)
  • Table 60. US & Canada Gefitinib API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 61. US & Canada Gefitinib API Revenue by Country (2018-2023) & (US$ Million)
  • Table 62. US & Canada Gefitinib API Revenue by Country (2024-2029) & (US$ Million)
  • Table 63. US & Canada Gefitinib API Sales by Country (2018-2023) & (MT)
  • Table 64. US & Canada Gefitinib API Sales by Country (2024-2029) & (MT)
  • Table 65. Europe Gefitinib API Sales by Type (2018-2023) & (MT)
  • Table 66. Europe Gefitinib API Sales by Type (2024-2029) & (MT)
  • Table 67. Europe Gefitinib API Revenue by Type (2018-2023) & (US$ Million)
  • Table 68. Europe Gefitinib API Revenue by Type (2024-2029) & (US$ Million)
  • Table 69. Europe Gefitinib API Sales by Application (2018-2023) & (MT)
  • Table 70. Europe Gefitinib API Sales by Application (2024-2029) & (MT)
  • Table 71. Europe Gefitinib API Revenue by Application (2018-2023) & (US$ Million)
  • Table 72. Europe Gefitinib API Revenue by Application (2024-2029) & (US$ Million)
  • Table 73. Europe Gefitinib API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 74. Europe Gefitinib API Revenue by Country (2018-2023) & (US$ Million)
  • Table 75. Europe Gefitinib API Revenue by Country (2024-2029) & (US$ Million)
  • Table 76. Europe Gefitinib API Sales by Country (2018-2023) & (MT)
  • Table 77. Europe Gefitinib API Sales by Country (2024-2029) & (MT)
  • Table 78. China Gefitinib API Sales by Type (2018-2023) & (MT)
  • Table 79. China Gefitinib API Sales by Type (2024-2029) & (MT)
  • Table 80. China Gefitinib API Revenue by Type (2018-2023) & (US$ Million)
  • Table 81. China Gefitinib API Revenue by Type (2024-2029) & (US$ Million)
  • Table 82. China Gefitinib API Sales by Application (2018-2023) & (MT)
  • Table 83. China Gefitinib API Sales by Application (2024-2029) & (MT)
  • Table 84. China Gefitinib API Revenue by Application (2018-2023) & (US$ Million)
  • Table 85. China Gefitinib API Revenue by Application (2024-2029) & (US$ Million)
  • Table 86. Asia Gefitinib API Sales by Type (2018-2023) & (MT)
  • Table 87. Asia Gefitinib API Sales by Type (2024-2029) & (MT)
  • Table 88. Asia Gefitinib API Revenue by Type (2018-2023) & (US$ Million)
  • Table 89. Asia Gefitinib API Revenue by Type (2024-2029) & (US$ Million)
  • Table 90. Asia Gefitinib API Sales by Application (2018-2023) & (MT)
  • Table 91. Asia Gefitinib API Sales by Application (2024-2029) & (MT)
  • Table 92. Asia Gefitinib API Revenue by Application (2018-2023) & (US$ Million)
  • Table 93. Asia Gefitinib API Revenue by Application (2024-2029) & (US$ Million)
  • Table 94. Asia Gefitinib API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 95. Asia Gefitinib API Revenue by Region (2018-2023) & (US$ Million)
  • Table 96. Asia Gefitinib API Revenue by Region (2024-2029) & (US$ Million)
  • Table 97. Asia Gefitinib API Sales by Region (2018-2023) & (MT)
  • Table 98. Asia Gefitinib API Sales by Region (2024-2029) & (MT)
  • Table 99. Middle East, Africa and Latin America Gefitinib API Sales by Type (2018-2023) & (MT)
  • Table 100. Middle East, Africa and Latin America Gefitinib API Sales by Type (2024-2029) & (MT)
  • Table 101. Middle East, Africa and Latin America Gefitinib API Revenue by Type (2018-2023) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Gefitinib API Revenue by Type (2024-2029) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Gefitinib API Sales by Application (2018-2023) & (MT)
  • Table 104. Middle East, Africa and Latin America Gefitinib API Sales by Application (2024-2029) & (MT)
  • Table 105. Middle East, Africa and Latin America Gefitinib API Revenue by Application (2018-2023) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Gefitinib API Revenue by Application (2024-2029) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Gefitinib API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 108. Middle East, Africa and Latin America Gefitinib API Revenue by Country (2018-2023) & (US$ Million)
  • Table 109. Middle East, Africa and Latin America Gefitinib API Revenue by Country (2024-2029) & (US$ Million)
  • Table 110. Middle East, Africa and Latin America Gefitinib API Sales by Country (2018-2023) & (MT)
  • Table 111. Middle East, Africa and Latin America Gefitinib API Sales by Country (2024-2029) & (MT)
  • Table 112. Scion Pharm Taiwan Company Information
  • Table 113. Scion Pharm Taiwan Description and Major Businesses
  • Table 114. Scion Pharm Taiwan Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 115. Scion Pharm Taiwan Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Scion Pharm Taiwan Recent Development
  • Table 117. Farmhispania Group Company Information
  • Table 118. Farmhispania Group Description and Major Businesses
  • Table 119. Farmhispania Group Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 120. Farmhispania Group Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Farmhispania Group Recent Development
  • Table 122. Chem Genix Company Information
  • Table 123. Chem Genix Description and Major Businesses
  • Table 124. Chem Genix Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 125. Chem Genix Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Chem Genix Recent Development
  • Table 127. Jeil Pharmaceutical Company Information
  • Table 128. Jeil Pharmaceutical Description and Major Businesses
  • Table 129. Jeil Pharmaceutical Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 130. Jeil Pharmaceutical Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Jeil Pharmaceutical Recent Development
  • Table 132. Zhuhai Rundu Pharma Company Information
  • Table 133. Zhuhai Rundu Pharma Description and Major Businesses
  • Table 134. Zhuhai Rundu Pharma Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 135. Zhuhai Rundu Pharma Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Zhuhai Rundu Pharma Recent Development
  • Table 137. Cipla Company Information
  • Table 138. Cipla Description and Major Businesses
  • Table 139. Cipla Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 140. Cipla Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Cipla Recent Development
  • Table 142. Brawn Laboratories Company Information
  • Table 143. Brawn Laboratories Description and Major Businesses
  • Table 144. Brawn Laboratories Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 145. Brawn Laboratories Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Brawn Laboratories Recent Development
  • Table 147. Nischem International Company Information
  • Table 148. Nischem International Description and Major Businesses
  • Table 149. Nischem International Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 150. Nischem International Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Nischem International Recent Development
  • Table 152. Zhejiang Hisun Pharmaceutical Company Information
  • Table 153. Zhejiang Hisun Pharmaceutical Description and Major Businesses
  • Table 154. Zhejiang Hisun Pharmaceutical Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 155. Zhejiang Hisun Pharmaceutical Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Zhejiang Hisun Pharmaceutical Recent Development
  • Table 157. Qilu Pharmaceutial Company Information
  • Table 158. Qilu Pharmaceutial Description and Major Businesses
  • Table 159. Qilu Pharmaceutial Gefitinib API Capacity Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
  • Table 160. Qilu Pharmaceutial Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. Qilu Pharmaceutial Recent Development
  • Table 162. Key Raw Materials Lists
  • Table 163. Raw Materials Key Suppliers Lists
  • Table 164. Gefitinib API Distributors List
  • Table 165. Gefitinib API Customers List
  • Table 166. Gefitinib API Market Trends
  • Table 167. Gefitinib API Market Drivers
  • Table 168. Gefitinib API Market Challenges
  • Table 169. Gefitinib API Market Restraints
  • Table 170. Research Programs/Design for This Report
  • Table 171. Key Data Information from Secondary Sources
  • Table 172. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Gefitinib API Product Picture
  • Figure 2. Global Gefitinib API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Gefitinib API Market Share by Type in 2022 & 2029
  • Figure 4. Purity ≥ 98 % Product Picture
  • Figure 5. Purity ≥ 99 % Product Picture
  • Figure 6. Global Gefitinib API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Gefitinib API Market Share by Application in 2022 & 2029
  • Figure 8. Gefitinib Tablets
  • Figure 9. Other
  • Figure 10. Gefitinib API Report Years Considered
  • Figure 11. Global Gefitinib API Capacity, Production and Utilization (2018-2029) & (MT)
  • Figure 12. Global Gefitinib API Production Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 13. Global Gefitinib API Production Market Share by Region (2018-2029)
  • Figure 14. Gefitinib API Production Growth Rate in North America (2018-2029) & (MT)
  • Figure 15. Gefitinib API Production Growth Rate in Europe (2018-2029) & (MT)
  • Figure 16. Gefitinib API Production Growth Rate in China (2018-2029) & (MT)
  • Figure 17. Gefitinib API Production Growth Rate in Japan (2018-2029) & (MT)
  • Figure 18. Global Gefitinib API Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 19. Global Gefitinib API Revenue 2018-2029 (US$ Million)
  • Figure 20. Global Gefitinib API Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 21. Global Gefitinib API Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 22. Global Gefitinib API Revenue Market Share by Region (2018-2029)
  • Figure 23. Global Gefitinib API Sales 2018-2029 ((MT)
  • Figure 24. Global Gefitinib API Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (MT)
  • Figure 25. Global Gefitinib API Sales Market Share by Region (2018-2029)
  • Figure 26. US & Canada Gefitinib API Sales YoY (2018-2029) & (MT)
  • Figure 27. US & Canada Gefitinib API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. Europe Gefitinib API Sales YoY (2018-2029) & (MT)
  • Figure 29. Europe Gefitinib API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. China Gefitinib API Sales YoY (2018-2029) & (MT)
  • Figure 31. China Gefitinib API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 32. Asia (excluding China) Gefitinib API Sales YoY (2018-2029) & (MT)
  • Figure 33. Asia (excluding China) Gefitinib API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 34. Middle East, Africa and Latin America Gefitinib API Sales YoY (2018-2029) & (MT)
  • Figure 35. Middle East, Africa and Latin America Gefitinib API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 36. The Gefitinib API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 37. The Top 5 and 10 Largest Manufacturers of Gefitinib API in the World: Market Share by Gefitinib API Revenue in 2022
  • Figure 38. Global Gefitinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 39. Global Gefitinib API Sales Market Share by Type (2018-2029)
  • Figure 40. Global Gefitinib API Revenue Market Share by Type (2018-2029)
  • Figure 41. Global Gefitinib API Sales Market Share by Application (2018-2029)
  • Figure 42. Global Gefitinib API Revenue Market Share by Application (2018-2029)
  • Figure 43. US & Canada Gefitinib API Sales Market Share by Type (2018-2029)
  • Figure 44. US & Canada Gefitinib API Revenue Market Share by Type (2018-2029)
  • Figure 45. US & Canada Gefitinib API Sales Market Share by Application (2018-2029)
  • Figure 46. US & Canada Gefitinib API Revenue Market Share by Application (2018-2029)
  • Figure 47. US & Canada Gefitinib API Revenue Share by Country (2018-2029)
  • Figure 48. US & Canada Gefitinib API Sales Share by Country (2018-2029)
  • Figure 49. U.S. Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 50. Canada Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 51. Europe Gefitinib API Sales Market Share by Type (2018-2029)
  • Figure 52. Europe Gefitinib API Revenue Market Share by Type (2018-2029)
  • Figure 53. Europe Gefitinib API Sales Market Share by Application (2018-2029)
  • Figure 54. Europe Gefitinib API Revenue Market Share by Application (2018-2029)
  • Figure 55. Europe Gefitinib API Revenue Share by Country (2018-2029)
  • Figure 56. Europe Gefitinib API Sales Share by Country (2018-2029)
  • Figure 57. Germany Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 58. France Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 59. U.K. Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 60. Italy Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 61. Russia Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 62. China Gefitinib API Sales Market Share by Type (2018-2029)
  • Figure 63. China Gefitinib API Revenue Market Share by Type (2018-2029)
  • Figure 64. China Gefitinib API Sales Market Share by Application (2018-2029)
  • Figure 65. China Gefitinib API Revenue Market Share by Application (2018-2029)
  • Figure 66. Asia Gefitinib API Sales Market Share by Type (2018-2029)
  • Figure 67. Asia Gefitinib API Revenue Market Share by Type (2018-2029)
  • Figure 68. Asia Gefitinib API Sales Market Share by Application (2018-2029)
  • Figure 69. Asia Gefitinib API Revenue Market Share by Application (2018-2029)
  • Figure 70. Asia Gefitinib API Revenue Share by Region (2018-2029)
  • Figure 71. Asia Gefitinib API Sales Share by Region (2018-2029)
  • Figure 72. Japan Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 73. South Korea Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 74. China Taiwan Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 75. Southeast Asia Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 76. India Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 77. Middle East, Africa and Latin America Gefitinib API Sales Market Share by Type (2018-2029)
  • Figure 78. Middle East, Africa and Latin America Gefitinib API Revenue Market Share by Type (2018-2029)
  • Figure 79. Middle East, Africa and Latin America Gefitinib API Sales Market Share by Application (2018-2029)
  • Figure 80. Middle East, Africa and Latin America Gefitinib API Revenue Market Share by Application (2018-2029)
  • Figure 81. Middle East, Africa and Latin America Gefitinib API Revenue Share by Country (2018-2029)
  • Figure 82. Middle East, Africa and Latin America Gefitinib API Sales Share by Country (2018-2029)
  • Figure 83. Brazil Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 84. Mexico Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 85. Turkey Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 86. Israel Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 87. GCC Countries Gefitinib API Revenue (2018-2029) & (US$ Million)
  • Figure 88. Gefitinib API Value Chain
  • Figure 89. Gefitinib API Production Process
  • Figure 90. Channels of Distribution
  • Figure 91. Distributors Profiles
  • Figure 92. Bottom-up and Top-down Approaches for This Report
  • Figure 93. Data Triangulation
  • Figure 94. Key Executives Interviewed
目次

This research report focuses on the Gefitinib API Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Gefitinib API Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Gefitinib API Market Size by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Purity ≥ 98 %
    • 1.2.3 Purity ≥ 99 %
  • 1.3 Market by Application
    • 1.3.1 Global Gefitinib API Market Size by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Gefitinib Tablets
    • 1.3.3 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Gefitinib API Production

  • 2.1 Global Gefitinib API Production Capacity (2018-2029)
  • 2.2 Global Gefitinib API Production by Region: 2018 VS 2022 VS 2029
  • 2.3 Global Gefitinib API Production by Region
    • 2.3.1 Global Gefitinib API Historic Production by Region (2018-2023)
    • 2.3.2 Global Gefitinib API Forecasted Production by Region (2024-2029)
    • 2.3.3 Global Gefitinib API Production Market Share by Region (2018-2029)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Executive Summary

  • 3.1 Global Gefitinib API Revenue Estimates and Forecasts 2018-2029
  • 3.2 Global Gefitinib API Revenue by Region
    • 3.2.1 Global Gefitinib API Revenue by Region: 2018 VS 2022 VS 2029
    • 3.2.2 Global Gefitinib API Revenue by Region (2018-2023)
    • 3.2.3 Global Gefitinib API Revenue by Region (2024-2029)
    • 3.2.4 Global Gefitinib API Revenue Market Share by Region (2018-2029)
  • 3.3 Global Gefitinib API Sales Estimates and Forecasts 2018-2029
  • 3.4 Global Gefitinib API Sales by Region
    • 3.4.1 Global Gefitinib API Sales by Region: 2018 VS 2022 VS 2029
    • 3.4.2 Global Gefitinib API Sales by Region (2018-2023)
    • 3.4.3 Global Gefitinib API Sales by Region (2024-2029)
    • 3.4.4 Global Gefitinib API Sales Market Share by Region (2018-2029)
  • 3.5 US & Canada
  • 3.6 Europe
  • 3.7 China
  • 3.8 Asia (excluding China)
  • 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

  • 4.1 Global Gefitinib API Sales by Manufacturers
    • 4.1.1 Global Gefitinib API Sales by Manufacturers (2018-2023)
    • 4.1.2 Global Gefitinib API Sales Market Share by Manufacturers (2018-2023)
    • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gefitinib API in 2022
  • 4.2 Global Gefitinib API Revenue by Manufacturers
    • 4.2.1 Global Gefitinib API Revenue by Manufacturers (2018-2023)
    • 4.2.2 Global Gefitinib API Revenue Market Share by Manufacturers (2018-2023)
    • 4.2.3 Global Top 10 and Top 5 Companies by Gefitinib API Revenue in 2022
  • 4.3 Global Gefitinib API Sales Price by Manufacturers
  • 4.4 Global Key Players of Gefitinib API, Industry Ranking, 2021 VS 2022 VS 2023
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Gefitinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.6 Global Key Manufacturers of Gefitinib API, Manufacturing Base Distribution and Headquarters
  • 4.7 Global Key Manufacturers of Gefitinib API, Product Offered and Application
  • 4.8 Global Key Manufacturers of Gefitinib API, Date of Enter into This Industry
  • 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Gefitinib API Sales by Type
    • 5.1.1 Global Gefitinib API Historical Sales by Type (2018-2023)
    • 5.1.2 Global Gefitinib API Forecasted Sales by Type (2024-2029)
    • 5.1.3 Global Gefitinib API Sales Market Share by Type (2018-2029)
  • 5.2 Global Gefitinib API Revenue by Type
    • 5.2.1 Global Gefitinib API Historical Revenue by Type (2018-2023)
    • 5.2.2 Global Gefitinib API Forecasted Revenue by Type (2024-2029)
    • 5.2.3 Global Gefitinib API Revenue Market Share by Type (2018-2029)
  • 5.3 Global Gefitinib API Price by Type
    • 5.3.1 Global Gefitinib API Price by Type (2018-2023)
    • 5.3.2 Global Gefitinib API Price Forecast by Type (2024-2029)

6 Market Size by Application

  • 6.1 Global Gefitinib API Sales by Application
    • 6.1.1 Global Gefitinib API Historical Sales by Application (2018-2023)
    • 6.1.2 Global Gefitinib API Forecasted Sales by Application (2024-2029)
    • 6.1.3 Global Gefitinib API Sales Market Share by Application (2018-2029)
  • 6.2 Global Gefitinib API Revenue by Application
    • 6.2.1 Global Gefitinib API Historical Revenue by Application (2018-2023)
    • 6.2.2 Global Gefitinib API Forecasted Revenue by Application (2024-2029)
    • 6.2.3 Global Gefitinib API Revenue Market Share by Application (2018-2029)
  • 6.3 Global Gefitinib API Price by Application
    • 6.3.1 Global Gefitinib API Price by Application (2018-2023)
    • 6.3.2 Global Gefitinib API Price Forecast by Application (2024-2029)

7 US & Canada

  • 7.1 US & Canada Gefitinib API Market Size by Type
    • 7.1.1 US & Canada Gefitinib API Sales by Type (2018-2029)
    • 7.1.2 US & Canada Gefitinib API Revenue by Type (2018-2029)
  • 7.2 US & Canada Gefitinib API Market Size by Application
    • 7.2.1 US & Canada Gefitinib API Sales by Application (2018-2029)
    • 7.2.2 US & Canada Gefitinib API Revenue by Application (2018-2029)
  • 7.3 US & Canada Gefitinib API Sales by Country
    • 7.3.1 US & Canada Gefitinib API Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 US & Canada Gefitinib API Sales by Country (2018-2029)
    • 7.3.3 US & Canada Gefitinib API Revenue by Country (2018-2029)
    • 7.3.4 U.S.
    • 7.3.5 Canada

8 Europe

  • 8.1 Europe Gefitinib API Market Size by Type
    • 8.1.1 Europe Gefitinib API Sales by Type (2018-2029)
    • 8.1.2 Europe Gefitinib API Revenue by Type (2018-2029)
  • 8.2 Europe Gefitinib API Market Size by Application
    • 8.2.1 Europe Gefitinib API Sales by Application (2018-2029)
    • 8.2.2 Europe Gefitinib API Revenue by Application (2018-2029)
  • 8.3 Europe Gefitinib API Sales by Country
    • 8.3.1 Europe Gefitinib API Revenue by Country: 2018 VS 2022 VS 2029
    • 8.3.2 Europe Gefitinib API Sales by Country (2018-2029)
    • 8.3.3 Europe Gefitinib API Revenue by Country (2018-2029)
    • 8.3.4 Germany
    • 8.3.5 France
    • 8.3.6 U.K.
    • 8.3.7 Italy
    • 8.3.8 Russia

9 China

  • 9.1 China Gefitinib API Market Size by Type
    • 9.1.1 China Gefitinib API Sales by Type (2018-2029)
    • 9.1.2 China Gefitinib API Revenue by Type (2018-2029)
  • 9.2 China Gefitinib API Market Size by Application
    • 9.2.1 China Gefitinib API Sales by Application (2018-2029)
    • 9.2.2 China Gefitinib API Revenue by Application (2018-2029)

10 Asia (excluding China)

  • 10.1 Asia Gefitinib API Market Size by Type
    • 10.1.1 Asia Gefitinib API Sales by Type (2018-2029)
    • 10.1.2 Asia Gefitinib API Revenue by Type (2018-2029)
  • 10.2 Asia Gefitinib API Market Size by Application
    • 10.2.1 Asia Gefitinib API Sales by Application (2018-2029)
    • 10.2.2 Asia Gefitinib API Revenue by Application (2018-2029)
  • 10.3 Asia Gefitinib API Sales by Region
    • 10.3.1 Asia Gefitinib API Revenue by Region: 2018 VS 2022 VS 2029
    • 10.3.2 Asia Gefitinib API Revenue by Region (2018-2029)
    • 10.3.3 Asia Gefitinib API Sales by Region (2018-2029)
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 China Taiwan
    • 10.3.7 Southeast Asia
    • 10.3.8 India

11 Middle East, Africa and Latin America

  • 11.1 Middle East, Africa and Latin America Gefitinib API Market Size by Type
    • 11.1.1 Middle East, Africa and Latin America Gefitinib API Sales by Type (2018-2029)
    • 11.1.2 Middle East, Africa and Latin America Gefitinib API Revenue by Type (2018-2029)
  • 11.2 Middle East, Africa and Latin America Gefitinib API Market Size by Application
    • 11.2.1 Middle East, Africa and Latin America Gefitinib API Sales by Application (2018-2029)
    • 11.2.2 Middle East, Africa and Latin America Gefitinib API Revenue by Application (2018-2029)
  • 11.3 Middle East, Africa and Latin America Gefitinib API Sales by Country
    • 11.3.1 Middle East, Africa and Latin America Gefitinib API Revenue by Country: 2018 VS 2022 VS 2029
    • 11.3.2 Middle East, Africa and Latin America Gefitinib API Revenue by Country (2018-2029)
    • 11.3.3 Middle East, Africa and Latin America Gefitinib API Sales by Country (2018-2029)
    • 11.3.4 Brazil
    • 11.3.5 Mexico
    • 11.3.6 Turkey
    • 11.3.7 Israel
    • 11.3.8 GCC Countries

12 Corporate Profiles

  • 12.1 Scion Pharm Taiwan
    • 12.1.1 Scion Pharm Taiwan Company Information
    • 12.1.2 Scion Pharm Taiwan Overview
    • 12.1.3 Scion Pharm Taiwan Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.1.4 Scion Pharm Taiwan Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 Scion Pharm Taiwan Recent Developments
  • 12.2 Farmhispania Group
    • 12.2.1 Farmhispania Group Company Information
    • 12.2.2 Farmhispania Group Overview
    • 12.2.3 Farmhispania Group Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.2.4 Farmhispania Group Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Farmhispania Group Recent Developments
  • 12.3 Chem Genix
    • 12.3.1 Chem Genix Company Information
    • 12.3.2 Chem Genix Overview
    • 12.3.3 Chem Genix Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.3.4 Chem Genix Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 Chem Genix Recent Developments
  • 12.4 Jeil Pharmaceutical
    • 12.4.1 Jeil Pharmaceutical Company Information
    • 12.4.2 Jeil Pharmaceutical Overview
    • 12.4.3 Jeil Pharmaceutical Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.4.4 Jeil Pharmaceutical Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 Jeil Pharmaceutical Recent Developments
  • 12.5 Zhuhai Rundu Pharma
    • 12.5.1 Zhuhai Rundu Pharma Company Information
    • 12.5.2 Zhuhai Rundu Pharma Overview
    • 12.5.3 Zhuhai Rundu Pharma Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.5.4 Zhuhai Rundu Pharma Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Zhuhai Rundu Pharma Recent Developments
  • 12.6 Cipla
    • 12.6.1 Cipla Company Information
    • 12.6.2 Cipla Overview
    • 12.6.3 Cipla Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.6.4 Cipla Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.6.5 Cipla Recent Developments
  • 12.7 Brawn Laboratories
    • 12.7.1 Brawn Laboratories Company Information
    • 12.7.2 Brawn Laboratories Overview
    • 12.7.3 Brawn Laboratories Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.7.4 Brawn Laboratories Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.7.5 Brawn Laboratories Recent Developments
  • 12.8 Nischem International
    • 12.8.1 Nischem International Company Information
    • 12.8.2 Nischem International Overview
    • 12.8.3 Nischem International Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.8.4 Nischem International Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.8.5 Nischem International Recent Developments
  • 12.9 Zhejiang Hisun Pharmaceutical
    • 12.9.1 Zhejiang Hisun Pharmaceutical Company Information
    • 12.9.2 Zhejiang Hisun Pharmaceutical Overview
    • 12.9.3 Zhejiang Hisun Pharmaceutical Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.9.4 Zhejiang Hisun Pharmaceutical Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.9.5 Zhejiang Hisun Pharmaceutical Recent Developments
  • 12.10 Qilu Pharmaceutial
    • 12.10.1 Qilu Pharmaceutial Company Information
    • 12.10.2 Qilu Pharmaceutial Overview
    • 12.10.3 Qilu Pharmaceutial Gefitinib API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.10.4 Qilu Pharmaceutial Gefitinib API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.10.5 Qilu Pharmaceutial Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Gefitinib API Industry Chain Analysis
  • 13.2 Gefitinib API Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Gefitinib API Production Mode & Process
  • 13.4 Gefitinib API Sales and Marketing
    • 13.4.1 Gefitinib API Sales Channels
    • 13.4.2 Gefitinib API Distributors
  • 13.5 Gefitinib API Customers

14 Gefitinib API Market Dynamics

  • 14.1 Gefitinib API Industry Trends
  • 14.2 Gefitinib API Market Drivers
  • 14.3 Gefitinib API Market Challenges
  • 14.4 Gefitinib API Market Restraints

15 Key Finding in The Global Gefitinib API Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer